DEPRESSION AND ANXIETY is a leading academic journal published by WILEY, dedicated to presenting cutting-edge research in the fields of clinical psychology, psychiatry, and mental health. With an impressive impact factor underscoring its prominence—ranked in the top quartile (Q1) for both clinical psychology and psychiatry, and occupying the 7th and 20th ranks in Scopus respectively—this journal serves as a pivotal resource for researchers, professionals, and students alike. Since its inception in 1996 and continuing through 2024, DEPRESSION AND ANXIETY has been at the forefront of disseminating findings that significantly impact our understanding of mental health issues. The journal's rigorous peer-review process ensures the highest quality of published works, making it an essential platform for scholars aiming to advance knowledge and contribute meaningfully to the mental health discourse.

Psycho-Oncologie is a specialized academic journal dedicated to the intersection of psychology and oncology, published by TECH SCIENCE PRESS. With an ISSN of 1778-3798 and E-ISSN of 1778-381X, this journal serves as an important platform for researchers and practitioners seeking to understand the psychological impact of cancer on patients and their families. Established in 2007 and converging with its findings through 2024, Psycho-Oncologie aims to disseminate high-quality research that enhances mental health and promotes effective treatment strategies within the oncological landscape. Although currently holding a Q4 ranking in disciplines such as Clinical Psychology and Oncology, the journal is committed to maintaining a high standard of research integrity and scientific rigor to foster future advancements. Although it operates under a non-open access model, the journal strives to make its valuable insights available to a broader audience. For those in the fields of psychology, oncology, and health care, Psycho-Oncologie is an essential resource for staying abreast of critical developments and contributing to interdisciplinary approaches in cancer treatment.

JOURNAL OF PAIN is a prestigious peer-reviewed journal published by Churchill Livingstone, dedicated to advancing the field of pain management and research. With an impressive impact factor and ranked in the top quartiles (Q1) in both Anesthesiology and Pain Medicine, as well as Neurology, the journal provides a vital platform for scholars and clinicians to disseminate their findings. The journal encompasses a broad range of topics related to pain, aiming to improve understanding, treatment, and management of pain conditions. It holds a significant position in the academic landscape, demonstrating strong metrics with Scopus rankings placing it in the 83rd percentile within its categories. Situated in the United States, the JOURNAL OF PAIN is an essential resource for researchers, professionals, and students seeking the latest insights and developments in pain research. To explore or submit your work, please check the Open Access options and contribute to this important field of study.

ZEITSCHRIFT FUR PSYCHOSOMATISCHE MEDIZIN UND PSYCHOTHERAPIE, published by Vandenhoeck & Ruprecht GmbH & Co KG, is a prominent journal in the fields of psychosomatic medicine and psychotherapy. With a rich history spanning from 1996 to 2024, this journal serves as a vital platform for disseminating research and advancements within applied psychology, clinical psychology, and psychiatry. The journal is categorized in the Q3 quartile for 2023 across various disciplines, reflecting its ongoing relevance and contribution to the scientific community. Despite not currently offering open access, it remains accessible to researchers and professionals through institutional subscriptions and libraries. By bridging the gap between empirical research and clinical practice, ZEITSCHRIFT FUR PSYCHOSOMATISCHE MEDIZIN UND PSYCHOTHERAPIE enhances the understanding of psychological processes and their implications for mental health, making it an indispensable resource for academics, practitioners, and students dedicated to the advancement of psychosomatic health.

JOURNAL OF PSYCHOPHARMACOLOGY, published by SAGE Publications Ltd, is a leading peer-reviewed journal that explores the intricate dynamics of pharmacological interventions in mental health and psychiatry. With an ISSN of 0269-8811 and an E-ISSN of 1461-7285, this esteemed journal has established its reputation in the field since its inception in 1987, converging research excellence into 2024. Recognized as a Q1 journal in various categories including Medicine (miscellaneous), Pharmacology, and Psychiatry and Mental Health, it ranks impressively within the top percentile in Scopus, standing at #64 out of 567 in Psychiatry and Mental Health, and #31 out of 272 in Medical Pharmacology. The journal serves as a vital resource for researchers, professionals, and students, providing insightful articles that advance the understanding of psychopharmacological effects and innovations. Although it does not offer open access, the journal's extensive research and impactful findings make it essential reading for anyone engaged in the field. For those seeking to stay at the forefront of psychopharmacology, the JOURNAL OF PSYCHOPHARMACOLOGY is an invaluable asset.

The Journal of Osteopathic Medicine, published by Walter de Gruyter GmbH, serves as a significant platform for advancing research and discourse within the realms of complementary and alternative medicine, as well as manual therapy. Since its inception in 2021, the journal has established a solid reputation with a commendable Q2 ranking in the respective categories for 2023, highlighting its impact and relevance in the field. The journal, based in Berlin, Germany, offers an Open Access model, ensuring that both emerging and established researchers have the opportunity to share their findings with a global audience, thereby fostering broader discussions and collaborations. With its commitment to publishing high-quality research, the Journal of Osteopathic Medicine aims to bridge the gap between scientific inquiry and practical application, ultimately enhancing the understanding and treatment approaches within osteopathy and related disciplines. Researchers, professionals, and students alike will find this journal an invaluable resource for staying updated with the latest advancements and methodologies in their field.

JOURNAL OF PSYCHOSOMATIC RESEARCH, published by Pergamon-Elsevier Science Ltd, stands as a premier international forum dedicated to the integration of psychological and physical health. Established in 1956, this esteemed journal has maintained a high impact in the field, currently ranking in the Q1 category for both Clinical Psychology and Psychiatry and Mental Health as of 2023. With an impressive Scopus ranking of #37/311 in Clinical Psychology and #95/567 in Psychiatry and Mental Health, it caters to a wide audience of researchers, clinicians, and students interested in the complex interplay between psychosocial factors and physical health outcomes. The journal publishes a diverse array of original research, reviews, and clinical studies, providing valuable insights into psychosomatic medicine. While it currently does not offer open access options, its robust editorial standards ensure that each publication contributes significantly to advancing the field. As the journal converges into its 68th year, it continues to be at the forefront of psychosomatic research, instrumental in shaping evidence-based practices and enhancing patient care.

Psychotherapie is a pivotal academic journal dedicated to the exploration and advancement of clinical psychology, published by the esteemed Springer. Since its inception in 2022, this journal has established a significant footprint in the field, currently positioned in the Q3 category for Clinical Psychology in 2023, as well as being recognized for its Scopus ranking within the top half of its category. This valuable resource features a broad scope of peer-reviewed articles aimed at both theoretical and practical developments in psychotherapy, making it a vital platform for researchers, professionals, and students alike. While the journal is not open access, it maintains a commitment to disseminating high-quality research that can influence best practices and contribute to the ongoing discourse in psychology. The journal's editorial objective is to connect scientific research with clinical practice, ensuring insights garnered from emerging studies are readily available to enhance therapeutic outcomes. Located in the USA with a strong presence in Germany, Psychotherapie promises to be an essential resource for anyone keen on innovative therapeutical approaches and psychological research.

SCHMERZ is a pivotal journal in the fields of anesthesiology, pain medicine, and clinical neurology, published by SPRINGER HEIDELBERG in Germany. With an ISSN of 0932-433X and an E-ISSN of 1432-2129, the journal is celebrated for its rigorous peer-reviewed articles contributing to the understanding and management of pain. Since its inception in 1987, SCHMERZ has developed an impressive readership, ranking in the Q3 category across multiple disciplines, including Anesthesiology and Pain Medicine, and Clinical Neurology. Operating within the 50th percentile for anesthesiology and the 32nd percentile in neurology, the journal stands as a critical resource for practitioners, researchers, and students engaging with current trends and advancements in pain research and treatment. While not currently offering open access options, SCHMERZ continues to strive toward disseminating high-quality research and fostering vital discussions in the management of pain. With a scope that aims to bridge clinical practices with scientific understanding, SCHMERZ invites contributions that will illuminate and advance the multifaceted nature of pain and its treatment.

Journal of Pain Research, published by DOVE MEDICAL PRESS LTD, stands at the forefront of the field of pain management and anesthesia, offering a critical platform for researchers and clinicians dedicated to advancing the understanding of pain and its treatment. With an Open Access model since 2008, this journal enhances accessibility to high-quality research, enabling a global audience to engage with innovative studies and findings. Recognized for its significant contributions, it has achieved a Q2 rank in Anesthesiology and Pain Medicine as of 2023, placing it among the top 30% in its category, and it holds a commendable Scopus rank of 41/136 in its field. Covering a broad scope encompassing clinical trials, pharmacology, and psychosocial aspects of pain, the journal invites submissions that advance both theoretical knowledge and practical applications, making it an invaluable resource for professionals, researchers, and students aiming to improve outcomes in pain management.